427 related articles for article (PubMed ID: 18633674)
1. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
[TBL] [Abstract][Full Text] [Related]
2. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
3. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
5. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
Körner H; Söreide K; Stokkeland PJ; Söreide JA
Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
8. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
9. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].
Forones NM; Tanaka M; Machado D; Falcão JB; Giovanoni M
Arq Gastroenterol; 1997; 34(1):3-6. PubMed ID: 9458953
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
[TBL] [Abstract][Full Text] [Related]
11. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer.
Wolf RF; Cohen AM
J Am Coll Surg; 1997 Jul; 185(1):60-4. PubMed ID: 9208962
[TBL] [Abstract][Full Text] [Related]
12. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
Forones NM; Tanaka M
Hepatogastroenterology; 1999; 46(26):905-8. PubMed ID: 10370636
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
14. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
[TBL] [Abstract][Full Text] [Related]
17. [Serum anti-p53 antibodies and CEA in monitoring of recurrences of colorectal cancer].
Bielicki D; Sulzyc-Bielicka V; Domagała W
Ann Acad Med Stetin; 2008; 54(3):99-104. PubMed ID: 19839520
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen elevation in post-hepatectomy patients with colorectal cancer liver metastasis indicates recurrence with high accuracy.
Hara M; Sato M; Takahashi H; Takayama S; Okada Y; Nagasaki T; Takeyama H
Hepatogastroenterology; 2013; 60(128):1935-9. PubMed ID: 24719930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
